These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1108146)

  • 1. [Tolerance and clinical action of carbamazepine under in a new suspension form, in 38 children and adolescents aged from 2 to 18, with epilepsy, sometimes complicated by behavior and character disorders].
    Sallou C
    Rev Neuropsychiatr Infant; 1975; 23(8-9):619-24. PubMed ID: 1108146
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of personality and behavior disorders in childhood epilepsy with Neuleptil].
    Nagayama T; Takeshita K; Kurakawa T
    No To Shinkei; 1967 Sep; 19(9):935-40. PubMed ID: 4866508
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication].
    Deisenhammer E
    Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with the psychopharmacological treatment with carbamazepine syrup in child behavior disorders].
    Rigardetto R
    Minerva Pediatr; 1974 Dec; 26(40):1995-2004. PubMed ID: 4453321
    [No Abstract]   [Full Text] [Related]  

  • 5. [Psychological approach to psychopharmacologic experimentation. Polycentric controlled study on the action of a new therapeutic agent in adolescents affected with character and personality disturbances].
    Galli PF; Alberti G; Bencini Bariatti MA; Cozzarini M; Micali C
    Clin Ter; 1969 Apr; 49(2):147-65. PubMed ID: 4947949
    [No Abstract]   [Full Text] [Related]  

  • 6. [Personal experience with Tegretol in nonconvulsive behavior disorders in children].
    Pereira JL
    Hospital (Rio J); 1969 Feb; 75(2):687-92. PubMed ID: 5311221
    [No Abstract]   [Full Text] [Related]  

  • 7. [Character and temperamental characteristics of children with behavior disorders of the epileptoid type].
    Milea S
    Neurol Psihiatr Neurochir; 1970; 15(3):255-63. PubMed ID: 5456231
    [No Abstract]   [Full Text] [Related]  

  • 8. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
    Ficker DM; Privitera M; Krauss G; Kanner A; Moore JL; Glauser T
    Neurology; 2005 Aug; 65(4):593-5. PubMed ID: 16116122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary report on the use of Tegretol sirup in epileptic patients].
    Monaco F; Riccio A; Furlan PM
    Riv Neurol; 1974 Mar; 44(2):123-33. PubMed ID: 4603758
    [No Abstract]   [Full Text] [Related]  

  • 10. Chewable carbamazepine for children with epilepsy.
    Ryan SW; Hartley R; Forsythe WI
    Dev Med Child Neurol; 1990 Dec; 32(12):1115-6. PubMed ID: 2286313
    [No Abstract]   [Full Text] [Related]  

  • 11. Is the therapy with carbamazepine more effective when measuring blood levels?
    Tatzer E; Groh C
    Padiatr Padol; 1980; 15(4):293-6. PubMed ID: 7007988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbamazepine and aggressive behavior: a review].
    Thibaut F; Colonna L
    Encephale; 1993; 19(6):651-6. PubMed ID: 12404785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution to the study of the effect of propericiazine on character and behavior disorders observed in children and adolescents].
    Duché DJ; Bourcier G
    Rev Neuropsychiatr Infant; 1969 Mar; 17(3):165-71. PubMed ID: 4389568
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbamazepine treatment of epileptic and psychic symptoms in children and adolescents.
    Donner M; Frisk M
    Ann Paediatr Fenn; 1965; 11(2):91-7. PubMed ID: 4955094
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with carbamazepine (Mazetol) an analysis of 156 cases.
    Maheshwari MC; Padmini R
    J Assoc Physicians India; 1982 Jan; 30(1):13-6. PubMed ID: 7169397
    [No Abstract]   [Full Text] [Related]  

  • 16. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
    Shinnar S; Pellock JM; Conry JA
    Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
    Protass LM
    Neurology; 2006 Mar; 66(6):957; author reply 957. PubMed ID: 16567735
    [No Abstract]   [Full Text] [Related]  

  • 18. [Performance and behavior disorders in childhood epilepsy].
    Freudenberg D
    Bibl Psychiatr Neurol; 1968; 135():1-116. PubMed ID: 4967991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment with Tegretal in children's convulsion disease].
    Wünsche W; Todt H; Munde B
    Dtsch Gesundheitsw; 1971 Apr; 26(16):745-9. PubMed ID: 4995961
    [No Abstract]   [Full Text] [Related]  

  • 20. [The psychology and seizures in children with motor alalia].
    Mnukhin SS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(10):1550-3. PubMed ID: 4121999
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.